Answers are grounded in this paper and cite their sources.
Platelet/Endothelial Cell Adhesion Molecule-1 (PECAM-1) is a 130-kDa integral membrane glycoprotein found on the surface of human platelets and leukocytes, and at the intercellular junctions of endothelial cells. PECAM-1 is a member of the immunoglobulin (Ig) gene superfamily, with six Ig-like loops in the extracytoplasmic domain, a 19-residue transmembrane domain, and a 118-amino acid cytoplasmic tail that contains potential sites for phosphorylation and lipid modification that could potentially modulate its adhesive properties and/or subcellular distribution. Antibodies to PECAM-1 interfere with the ability of endothelial cells to form normal cellular junctions, suggesting that PECAM-1 functions in forming or stabilizing the vascular bed. Anti-PECAM-1 antibodies also have been reported to block neutrophil and monocyte chemotaxis in response to lipopolysaccaride, suggesting that PECAM-1 may play a role in leukocyte motility. PECAM-1-transfected murine L cells, but not untransfected L cells, aggregate in a calcium- and PECAM-1-dependent manner, demonstrating directly that PECAM-1 functions as a cell-cell adhesion molecule. PECAM-1 becomes highly phosphorylated in response to cellular activation and, coincident with phosphorylation, associates with the cytoskeleton of activated, but not resting platelets. The engagement of PECAM-1 with the platelet cytoskeleton enables it to move large distances within the plane of the membrane and may similarly account for the ability of PECAM-1 to localize to the intercellular borders of endothelial cells once cell-cell contact has been achieved. Finally, engagement of PECAM-1 causes up-regulation of integrin function on leukocytes, implicating PECAM-1 as a trigger molecule that may regulate leukocyte trafficking through the vessel wall.
No takes yet. Share an insight, caveat, or question.
Peter J. Newman (1994) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: